Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05217524 · ClinicalTrials.gov registry record
Samsung Galaxy Watch Body Composition Study
A clinical trial, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- 110
- Enrollment target
NCT05217524 is a clinical trial that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 110 participants.
The verdict
NCT05217524 has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- 110 participants
- Enrollment target
Study Summary
The aim of this study is to acquire impedance measurements of the adult human body with a novel bioimpedance device housed inside a watch case and to compare derived estimates of body composition measured by dual-energy x-ray absorptiometry (DXA) and other bioimpedance analysis (BIA) systems.
Interventions
- DEVICE Galaxy BIA watch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2021-05-01 |
| Est. Completion | 2022-01-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05217524
The ClinicalTrials.gov registry entry for NCT05217524 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pennington Biomedical Research Center, which has 258 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Galaxy BIA watch is the first listed.
NCT05217524 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05217524 about?
NCT05217524 is a clinical study titled "Samsung Galaxy Watch Body Composition Study". The aim of this study is to acquire impedance measurements of the adult human body with a novel bioimpedance device housed inside a watch case and to compare derived estimates of body composition measured by dual-energy x-ray absorptiometry (DXA) and other bioimpedance analysis (BIA) systems.
What is the current status of trial NCT05217524?
This trial is currently completed. The enrollment target is 110 participants. The study started on 2021-05-01. Estimated completion is 2022-01-01.
What interventions are being tested in trial NCT05217524?
The interventions under investigation include: Galaxy BIA watch (DEVICE).
Who is sponsoring clinical trial NCT05217524?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.